4//SEC Filing
Robbins Andrew R 4
Accession 0000899243-21-006403
CIK 0001622229other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 8:17 PM ET
Size
5.6 KB
Accession
0000899243-21-006403
Insider Transaction Report
Form 4
Robbins Andrews R
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2021-02-10+315,200→ 315,200 totalExercise: $10.17Exp: 2031-02-10→ Common Stock (315,200 underlying)
Footnotes (1)
- [F1]This stock option shall vest in equal monthly installments over a four year period.
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001590157
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 8:17 PM ET
- Size
- 5.6 KB